Federal Register Notice: FDA’s proposed collection of information, “Comparative Price Information in Direct-to-Consumer and Professional Prescription Drug Advertisements,” has been submitted to the Office of Management and Budget for review and clearance under the Paperwork Reduction Act of 1995. To view this notice, click here.
